Company / FCF Margin
ANAPTYSBIO, INC FCF Margin History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
8.4%
FY2025
5-year range
-879.0% / 8.4%
FY2021-FY2025
Trend
+105.6%
vs FY2024
Sector context
#49 of 134
Health Care
What the data says
At 8.4%, ANAPTYSBIO, INC's fcf margin ranks #49 of 134 in the Health Care sector. FCF Margin has fluctuated over the past 8 years, ranging from -991.4% in FY2020 to 8.4% in FY2025.
Based on SEC 10-K filings.
8.4% in FY2025 with a 5-year CAGR of +999.7%.
Improved from -708.8% to 8.4% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +28.0pp
- 5-Year Change
- +999.7pp
- 10-Year Change
- -
Sector benchmark
#49 of 134 in Health CareTop 37% of 134This company 8.4% Sector average -637.8%
▼
+101.3% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 105.6% year-over-year.
- Currently 646.1pp above the Health Care sector average.
- Lowest fcf margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 8.4% | +105.6% |
| FY2024 | -148.7% | +79.0% |
| FY2023 | -708.8% | -3510.7% |
| FY2022 | -19.6% | +97.8% |
| FY2021 | -879.0% | +11.3% |
| FY2020 | -991.4% | -402.5% |
| FY2019 | -197.3% | - |
| FY2018 | - | - |
| FY2017 | -56.5% | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026